Alternative Investment Posts
Andrea Alms Video: Money in Motion 145 - Biotech IPO Market Forecast 2025
TRANSCRIPT Hello, my name is Andrea Alms. I'm a technology investor and financial manager and this is your money in motion. Before we look at 2025, let's place it in context. Since 2014, the U.S. biotech IPO issuance still the proceeds and the number of IPOs have dropped more than 80% in 2023. It appears there has a notable change in the type of IPOs, with all ten companies having clinical trial assets and roughly a
Member Posts:
Log In for More